← All diseases Cancer

Childhood cancer: neuroblastoma and DIPG

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (24)Meta-analysis (6)Treatment guideline (3)Systematic review (10)Phase 3 study (4)Randomized trial (1)Clinical trial (578)Review article (123)Early study (phase 1 or 2) (33)Laboratory or animal research (133)Case report (85)Commentary or editorial (15)Retracted publication (2) Studies currently recruiting participants only (34)

Filter

Publications and studies (2128)

• Incidence and Severity of Carboplatin-Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria. (2026/07/27) ♡
• An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma. (2026/07/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. R-loops: Biological functions, regulatory mechanisms, and therapeutic implications in brain diseases—A review. (2026/07/27) ♡
• Renal Ewing Sarcoma Mimicking Neuroblastoma: A Multitracer PET/Scintigraphic Imaging Pitfall. (2026/07/27) ♡
• Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma. (2026/07/25) ♡
• Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma. (2026/07/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Adult-Onset Central Nervous System Embryonal Tumor With Neuronal Differentiation: A Diagnostic Challenge. (2026/07/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MYCN-driven metabolic remodelling of the tumour microenvironment in neuroblastoma: implications for stromal biology and CAF heterogeneity. (2026/07/24) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Systems pharmacology and targeted transcriptional profiling suggest the putative neuroprotective role of Leuconostoc mesenteroides in an in vitro Alzheimer's disease model. (2026/07/24) ♡
• Cancer treatments-related factors for subsequent soft-tissue sarcoma in childhood cancer survivors. (2026/07/24) ♡
• Tumor-targeted CD40 ligand-functionalized extracellular vesicle mimetics enable chemoimmunotherapy for neuroblastoma. (2026/07/24) ♡
• Model-dependent GD2 upregulation in Ewing sarcoma with the EZH2 inhibitor tazemetostat: Prerequisites for combination with GD2-specific CAR T cells. (2026/07/24) ♡
• Partial Remission in Pediatric Relapsed Neuroblastoma After Multiple Cycle Low-Dose 211At-MABG Therapy. (2026/07/24) ♡
• Long-Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group. (2026/07/23) ♡
• Factors Impacting Overall Survival Post-Relapse in High-Risk Neuroblastoma: Children's Oncology Group Outcomes From 2000 to 2019. (2026/07/23) ♡
• Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma. (2026/07/23) ♡
• Electroactive hydrogel scaffolds based on gelatin and poly (2-methacryloyloxyethyl phosphorylcholine-b-poly(L-tyrosine) for potential neural tissue engineering applications. (2026/07/23) ♡
• Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies. (2026/07/23) ♡
• Generation and characterization of an anti ITGB4 monoclonal antibody that blocks Zika virus entry. (2026/07/23) ♡
• ATRX large deletions and truncating mutations are associated with primary induction chemotherapy resistance in high-risk neuroblastoma: a multicenter propensity-weighted cohort study. (2026/07/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies. (2026/07/22) ♡
• Incidence trends, mortality, and treatment-related toxicity in osteosarcoma, neuroblastoma, and acute lymphoblastic leukemia in Kazakhstan. (2026/07/21) ♡
• Letter to the Editor: Horner Syndrome as a Complication of Neuroblastoma Treatment. (2026/07/21) ♡
• Neuroprotective Effect of Physiological Circulating Phenolic Metabolites Against Oxidative Stress- and Neuroinflammation-Induced in Human Cellular Models. (2026/07/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Evolution of intratumoral spatial heterogeneity assessed by [(68)Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma. (2026/07/21) ♡
• Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy. (2026/07/21) ♡
• MicroRNA sequencing reveals modulation of neurodegenerative miRNAs by Withania somnifera in human neuroblastoma SK-N-SH cells. (2026/07/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Next-generation CAR immunotherapy for neuroblastoma: expanding the role of immune cell platforms. (2026/07/20) ♡
• Clinical Impact of Germline Multigene Sequencing in Pediatric Cohorts with a Wide Spectrum of Neoplasms. (2026/07/18) ♡
• Molecular mechanisms of the hypothalamus miR-27a/ PRKCA pathway in regulating neuronal function and aggression-related behavior. (2026/07/18) ♡
• Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma. (2026/07/17) ♡
• Temporal Patterns of Clinical Events as Markers of Terminal Decline in Pediatric Oncology Patients. (2026/07/17) ♡
• Spiramide and Hydroquinidine Inhibit Proliferation and Migration While Promoting Apoptosis and Oxidative Stress in Neuroblastoma Cells. (2026/07/17) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Improving the yield and biological activity of sage essential oil using NADES: in vitro and in silico insights. (2026/07/16) ♡
• Triple-amplified sequential activation allosteric DNA biosensor for in vivo quantitative detection of MYCN copy number in neuroblastoma. (2026/07/16) ♡
• 5-hydroxymethylcytosine deposition mediates Polycomb repressive complex 2 function in MYCN-amplified neuroblastoma. (2026/07/16) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Abiraterone Acetate Affects Gene Expression Profile in a Human Male Neuronal Cell Line: Potential Mechanism for Cognitive Deficits with Prostate Cancer Therapy. (2026/07/16) ♡
• VLX1570 suppresses neuroblastoma growth through inhibition of PCNA-associated proliferative signaling and potentiates cisplatin antitumor activity. (2026/07/15) ♡
• Postoperative [18F]FDOPA and [18F]FDG PET Semiquantitative Scoring System for Risk Stratification in Neuroblastoma: A Three-tier Classification Approach. (2026/07/15) ♡
• Structural Tuning of HEWL Amyloid Polymorphs Enhances Antibacterial Activity Against Gram-Positive and Gram-Negative Pathogens. (2026/07/14) ♡
• Exploring the Mechanism of Action of Isorhynchophylline in Stroke Based on Network Pharmacology and Molecular Docking Technology. (2026/07/13) ♡
• Restoring Parkin Function: An AAV Gene Therapy Approach for Early-Onset Parkinson's Disease. (2026/07/13) ♡
• Polyethylene Terephthalate Glycol-Modified (PETG) as a Reusable and Biocompatible Substrate for Cell Culture Applications. (2026/07/11) ♡
• Synthesis, characterization, and biocompatibility evaluation of donepezil-loaded magnetite-PLGA nanoparticles in neuroblastoma cells. (2026/07/10) ♡
• Multi-Targeted Anti-Alzheimer's Effects of Tri-Sannibat-Phol: Biological Evaluation, Behavioral Validation, and LC-MS/MS Phytochemical Profiling. (2026/07/09) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of Fermentation and Oxidative Degradation on the Composition, Antioxidant Activity, ACE Inhibitory Activity, and In Vitro Neuroprotective Potential of Soybean-Derived Kefir Polysaccharide-Rich Extracts. (2026/07/03) ♡
• Repurposing tricyclic drugs as cancer therapeutics: comparative analysis of antitumorigenic effects of chlorpromazine, amitriptyline and imipramine. (2026/07/02) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Multiple Endocrine Neoplasia Type 5 due to Germline MAX Mutations: A Systematic Review of Tumor Spectrum and Clinical Features. (2026/07/01) ♡
• Surface decoration of solid lipid nanoparticles with cyclic RGD peptides for precision therapy in high-risk neuroblastoma. (2026/07/01) ♡
• Cholesterol overload promotes mitochondria-mediated apoptosis with impaired mitochondrial unfolded protein response and mitophagy in SH-SY5Y cells. (2026/07/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.